Massachusetts Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Healthcare Journal.

Press releases published on July 3, 2026

Jul. 3, 2026

Mark Leeds, D.O. PA Launches FloridaTaper.com, a Free Educational Resource on Benzodiazepine Tapering, Withdrawal, and BIND

Indeterminate GlobeNewswire

Jul. 3, 2026

Appili Therapeutics Announces Receipt from NIAID of a Notice of Termination for Convenience on the Contract for the VXV-01 Program

Indeterminate GlobeNewswire

Jul. 3, 2026

Innovative Chiral Building Blocks Solution Provider: Expanding Molecular Diversity from AiFChem

Indeterminate EIN Presswire

Jul. 3, 2026

How an AI-driven Chemical Building Blocks Vendor AiFChem Helps Accelerate Lab Discovery

Indeterminate EIN Presswire

Jul. 3, 2026

Court Approval of a Restructuring Transaction Allowing Continuation of Uninterrupted Operations

Indeterminate GlobeNewswire

Jul. 3, 2026

Top 10 Benefits of Utilizing an AI-Driven Custom Synthesis & Building Blocks Platform

Indeterminate EIN Presswire

Jul. 3, 2026

Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08

Indeterminate GlobeNewswire

Jul. 3, 2026

HorseBoost Gummies Officially Debut Featuring the Trendy Horse Gelatin Salt Trick Recipe for Male Enhancement

Indeterminate GlobeNewswire

Jul. 3, 2026

Burntide Gummies 2026 Update Highlights Ingredient Panel, Supplement Facts and Customer Service Support Details

Indeterminate GlobeNewswire

Jul. 3, 2026

Dental Consumables Market Size Expected to Reach USD 54.0 Billion by 2031 | MarketsandMarkets™

Indeterminate GlobeNewswire

Jul. 3, 2026

HEALBE's Technology Powers SHARP's First Health-Focused Smartwatch

Indeterminate GlobeNewswire

Jul. 3, 2026

COSCIENS Biopharma Inc. Completes Share Capital Amendment

Indeterminate GlobeNewswire

Jul. 3, 2026

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 3, 2026

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire